{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:35:33Z","timestamp":1788482133006,"version":"build-2803163510"},"reference-count":36,"publisher":"Scientific Scholar","issue":"Suppl 1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"abstract":"\n Background & objectives:<\/jats:title>\n Despite their high occurrence and associated significant level of morbidity manifesting as spectrum of clinical symptoms, the pathogenesis of uterine leiomyomas (ULs) remains unclear. We investigated expression profile of tumour suppressor genes PTEN<\/jats:italic> (phosphatase and tensin homolog deleted on chromosome ten) and LKB1<\/jats:italic> (liver kinase B1), and key signaling components of P13K (phosphatidylinositol 3-kinase)\/Akt (protein kinase B)\/mTOR (mammalian target of rapamycin) pathway in leiomyomas and adjacent normal myometrium in women of reproductive age, to explore the possibility of targeting this pathway for future therapeutic implications.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Real time PCR (qPCR) was used to quantify relative gene expression levels of PTEN<\/jats:italic>, Akt1<\/jats:italic>, Akt2<\/jats:italic>, mTOR<\/jats:italic>, LKB1<\/jats:italic> and VEGFA<\/jats:italic> (vascular endothelial growth factor A) in leiomyoma as compared to adjacent normal myometrium. Immunohistochemistry was subsequently performed to analyze expression of PTEN, phospho-Akt, phospho-mTOR, phospho-S6, LKB1 and VEGFA in leiomyoma and adjacent normal myometrium.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Significant upregulation of PTEN<\/jats:italic> (2.52 fold; P<\/jats:italic>=0.03) and LKB1<\/jats:italic> (3.93 fold; P<\/jats:italic>=0.01), and downregulation of VEGFA<\/jats:italic> (2.95 fold; P<\/jats:italic>=0.01) genes were observed in leiomyoma as compared to normal myometrium. Transcript levels of Akt1<\/jats:italic>, Akt2<\/jats:italic> and mTOR<\/jats:italic> did not vary significantly between leiomyoma and myometrium. An increased immunoexpression of PTEN (P<\/jats:italic>=0.015) and LKB1 (P<\/jats:italic><0.001) and decreased expression of VEGFA (P<\/jats:italic>=0.01) was observed in leiomyoma as compared to myometrium. Immunostaining for activated (phosphorylated) Akt, mTOR and S6 was absent or low in majority of leiomyoma and myometrium.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Upregulation of PTEN and LKB1 in concert with negative or low levels of activated Akt, mTOR and S6 indicates that PI3K\/Akt\/mTOR pathway may not play a significant role in pathogenesis of leiomyoma.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/0971-5916.191808","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T08:36:33Z","timestamp":1476088593000},"page":"S112-S119","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["PI3K\/Akt\/mTOR signaling & its regulator tumour suppressor genes PTEN & LKB1 in human uterine leiomyomas"],"prefix":"10.25259","volume":"143","author":[{"given":"Annu","family":"Makker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhu Mati","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Ali","family":"Mahdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjoo","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amita","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-15-20241212","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1933719114533728","article-title":"Uterine fibroids: Clinical manifestations and contemporary management","volume":"21","author":"Doherty","year":"2014","journal-title":"Reprod Sci"},{"key":"R2-15-20241212","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fertnstert.2013.03.007","article-title":"Complex networks of multiple factors in the pathogenesis of uterine leiomyoma","volume":"100","author":"Islam","year":"2013","journal-title":"Fertil Steril"},{"key":"R3-15-20241212","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"R4-15-20241212","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jsbmb.2006.09.030","article-title":"Progesterone signaling in breast and endometrium","volume":"102","author":"Ballare","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R5-15-20241212","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.steroids.2007.03.001","article-title":"Effect of estrogen and inhibition of Phosphatidylinositol-3 kinase on Akt and FOXO1 in rat uterus","volume":"72","author":"Lengyel","year":"2007","journal-title":"Steroids"},{"key":"R6-15-20241212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5732\/cjc.013.10057","article-title":"Targeting the PI3K-Akt-mTOR signaling network in cancer","volume":"32","author":"Khan","year":"2013","journal-title":"Chin J Cancer"},{"key":"R7-15-20241212","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1210\/me.2013-1059","article-title":"Uterine-specific loss of Tsc2 leads to myometrial tumors in both the uterus and lungs","volume":"27","author":"Prizant","year":"2013","journal-title":"Mol Endocrinol"},{"key":"R8-15-20241212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/09513590.2011.583955","article-title":"PI3K-Akt and MAP kinase signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update","volume":"28","author":"Makker","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"R9-15-20241212","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1535-6108(03)00248-4","article-title":"Targeting the PI3K-Akt pathway in human cancer: rationale and premise","volume":"4","author":"Luo","year":"2003","journal-title":"Cancer Cell"},{"key":"R10-15-20241212","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrc2676","article-title":"The LKB1-AMPK pathway: metabolism and growth control in tumor suppression","volume":"9","author":"Shackelford","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R11-15-20241212","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/0971-5851.76197","article-title":"Targeting mTOR pathway: a new concept in cancer therapy","volume":"31","author":"Advani","year":"2010","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R12-15-20241212","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1478-3231.2009.02117.x","article-title":"Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signaling in hepatocellular carcinoma","volume":"30","author":"Hui","year":"2010","journal-title":"Liver Int"},{"key":"R13-15-20241212","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.onc.1202486","article-title":"Somatic mutations of the Peutz-Jeghers syndrome gene, LKB1\/STK11, in malignant melanoma","volume":"18","author":"Guldberg","year":"1999","journal-title":"Oncogene"},{"key":"R14-15-20241212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.oraloncology.2011.10.003","article-title":"VEGF-A immunohistochemical and mRNA expression in tissues and its serum levels in potentially malignant oral lesions and oral squamous cell carcinomas","volume":"48","author":"Nayak","year":"2012","journal-title":"Oral Oncol"},{"key":"R15-15-20241212","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1073\/pnas.91.26.12721","article-title":"Molecular evidence for two forms of Crohn disease","volume":"91","author":"Gilberts","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R16-15-20241212","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/jcp.48.9.876","article-title":"A \u201cquickscore\u201d method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas","volume":"48","author":"Detre","year":"1995","journal-title":"J Clin Pathol"},{"key":"R17-15-20241212","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11745-012-3746-2","article-title":"Sphingolipid content in the human uterus and pair-matched uterine leiomyomas remains constant","volume":"48","author":"Pawel","year":"2013","journal-title":"Lipids"},{"key":"R18-15-20241212","first-page":"921","article-title":"17\u03b2-estradiol induces up-regulation of PTEN and PPAR\u03b3 in leiomyoma cells, but not in normal cells","volume":"36","author":"Jeong","year":"2010","journal-title":"Int J Oncol"},{"key":"R19-15-20241212","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jsbmb.2006.08.006","article-title":"Phosphorylation of PTEN (phosphatase and tensin homologue deleted on chromosome ten) protein is enhanced in human fibromyomatous uteri","volume":"103","author":"Kov\u2019acs","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R20-15-20241212","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1933719107305866","article-title":"Expression of proliferative and preapoptotic molecules in human myometrium and leiomyoma throughout the menstrual cycle","volume":"14","author":"Kayisli","year":"2007","journal-title":"Reprod Sci"},{"key":"R21-15-20241212","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/cancers2031576","article-title":"The emerging role of the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin signaling network in cancer stem cell biology","volume":"2","author":"Martelli","year":"2010","journal-title":"Cancer"},{"key":"R22-15-20241212","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000320784","article-title":"Downregulation of the integrin \u03b1v signaling pathway in uterine leiomyomas","volume":"71","author":"Tsai","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"R23-15-20241212","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.fertnstert.2010.11.028","article-title":"Increased expression of tuberin in human uterine leiomyoma","volume":"95","author":"Cui","year":"2011","journal-title":"Fertil Steril"},{"key":"R24-15-20241212","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2119\/2007-00101.YU","article-title":"Differential expression of receptor tyrosine kinases (RTKs) and IGF-1 pathway activation in human uterine leiomyomas","volume":"14","author":"Yu","year":"2008","journal-title":"Mol Med"},{"key":"R25-15-20241212","first-page":"134","article-title":"Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications","volume":"4","author":"Dhingra","year":"2011","journal-title":"Int J Clin Exp Pathol"},{"key":"R26-15-20241212","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jsbmb.2003.09.007","article-title":"Differential expression of Akt\/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium","volume":"87","author":"Kov\u2019acs","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R27-15-20241212","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.fertnstert.2007.10.083","article-title":"Expression of insulin-like growth factors (IGFs) and IGF signaling: molecular complexity in uterine leiomyomas","volume":"91","author":"Peng","year":"2009","journal-title":"Fertil Steril"},{"key":"R28-15-20241212","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1073\/pnas.1215759110","article-title":"Loss of repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway","volume":"110","author":"Varghese","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R29-15-20241212","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1158\/0008-5472.CAN-08-4471","article-title":"Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway","volume":"69","author":"Crabtree","year":"2009","journal-title":"Cancer Res"},{"key":"R30-15-20241212","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000072074","article-title":"Different proliferative and apoptotic activity in peripheral versus central parts of human uterine leiomyomas","volume":"55","author":"Bourlev","year":"2003","journal-title":"Gynecol Obstet Invest"},{"key":"R31-15-20241212","doi-asserted-by":"crossref","first-page":"e1002906","DOI":"10.1371\/journal.pgen.1002906","article-title":"Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian target of rapamycin complex 1","volume":"8","author":"Tanwar","year":"2012","journal-title":"PLoS Genet"},{"key":"R32-15-20241212","first-page":"175","article-title":"Akt blocks the tumor suppressor activity of LKB1 by promoting phosphorylation-dependent nuclear retention through 14-3-3 proteins","volume":"4","author":"Liu","year":"2012","journal-title":"Am J Transl Res"},{"key":"R33-15-20241212","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.1062074","article-title":"Vascular abnormalities and deregulation of VEGF in LKB1-deficient mice","volume":"293","author":"Ylikorkala","year":"2001","journal-title":"Science"},{"key":"R34-15-20241212","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1042\/cs1010691","article-title":"Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium","volume":"101","author":"Gentry","year":"2001","journal-title":"Clin Sci"},{"key":"R35-15-20241212","first-page":"299","article-title":"[Leiomyoma ve normal myometrium da immunohistokimyasalvaskulerendotelyal growth factor (VEGF) ekspresyonu]","volume":"11","author":"Ozcakyr","year":"2003","journal-title":"Turk Fertilite Dergisi"},{"key":"R36-15-20241212","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejogrb.2012.05.021","article-title":"Does vascular endothelial growth factor participate in uterine myoma growth stimulation?","volume":"164","author":"Wolanska","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201643001-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:57:53Z","timestamp":1751497073000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/pi3k-akt-mtor-signaling-its-regulator-tumour-suppressor-genes-pten-lkb1-in-human-uterine-leiomyomas\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":36,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.4103\/0971-5916.191808","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}